Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
2021-05-19
PHARMACEUTICALS AS UNDER METFORMIN HCL ER TABODUCT CODE NO. 61 P C A 55 H. T. S NO. 3004 .90.92.40
PHARMACEUTICALS AS UNDER METFORMIN HCL ER TABODUCT CODE NO. 61 P C A 55 H. T. S NO. 3004 .90.92.40
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9,863
KG
45
PKG
***
USD
2022-04-05
1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 030929 FDA PRODUCT CODE NO. 65 J D A 27 H. T . S NO. 3006.60.00.00 ANDA NO. 200538 THERA
1X40RH SAID TO CONTAIN PHARMACEUTICALS AS UN 030929 FDA PRODUCT CODE NO. 65 J D A 27 H. T . S NO. 3006.60.00.00 ANDA NO. 200538 THERA
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6,678
KG
960
PKG
***
USD
2020-12-02
39 PALLET CONTAINING 1660 CARTONS PHARMACEUTICALS A S UNDER NORGEST/EE 0.18,0 .215,0.25/0.035MG 84 NDC C ODE:68462056529 FDA PRODUC T CODE NO.:65 J D A 27 H. T. S NO.:3006.60.00.00AND A NO.: 200494 THERAPEUTICE USE: - ORAL C ONTRACEPTIVE S NORETHINDRONE A
39 PALLET CONTAINING 1660 CARTONS PHARMACEUTICALS A S UNDER NORGEST/EE 0.18,0 .215,0.25/0.035MG 84 NDC C ODE:68462056529 FDA PRODUC T CODE NO.:65 J D A 27 H. T. S NO.:3006.60.00.00AND A NO.: 200494 THERAPEUTICE USE: - ORAL C ONTRACEPTIVE S NORETHINDRONE A
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6,722
KG
39
PKG
***
USD
2020-11-24
45 PALLET CONTAINING 2485 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAPSU LES 20MG 90 S NDC CODE:684 62039690 FDA PRODUCT CODE NO. :62KCF10 H. T. S NO.:30 04.90.9160 ANDA NO.: 91672 THERAPEUTICE USE TREATMEN T OF TREAT GASTROESOPHAGEA L REFLUX DISEAS
45 PALLET CONTAINING 2485 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAPSU LES 20MG 90 S NDC CODE:684 62039690 FDA PRODUCT CODE NO. :62KCF10 H. T. S NO.:30 04.90.9160 ANDA NO.: 91672 THERAPEUTICE USE TREATMEN T OF TREAT GASTROESOPHAGEA L REFLUX DISEAS
53313, JAWAHARLAL NEHRU
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
14,962
KG
45
PKG
***
USD
2020-09-10
PHARMACEUTICALS AS UNDER TRIAMCINOLONE ACE OICODE NO.64 L C J 61 H. T. S NO. 3004.49.00 .50 3004.40.49.50 3004.90.92.45
PHARMACEUTICALS AS UNDER TRIAMCINOLONE ACE OICODE NO.64 L C J 61 H. T. S NO. 3004.49.00 .50 3004.40.49.50 3004.90.92.45
53313, JAWAHARLAL NEHRU
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
6,265
KG
33
PKG
***
USD
2021-01-09
PHARMACEUTICALS AS UNDER TRIAMCINOLONE ACE OICODE NO.64 L C J 61 H. T. S NO. 3004.49.00 .50 ANDA NO.206379 THERAPEUTICE . .
PHARMACEUTICALS AS UNDER TRIAMCINOLONE ACE OICODE NO.64 L C J 61 H. T. S NO. 3004.49.00 .50 ANDA NO.206379 THERAPEUTICE . .
53313, JAWAHARLAL NEHRU
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
1,331
KG
19
PKG
***
USD
2020-09-11
(18 PALLETS CONTAINING 419 CARTONS) PHARMACEUTICALS AS UNDER DESMOPRESSIN ACET ATE TABLETS0.2MG 100S NDC CODE:68462027601 FDA PROD UCT CODE NO.: 61QCA03 H. T . S NO.: 2937.19.0000 ANDA NO.:201831 THERAPEUTICE U SE: - MANAGEM ENT OF CENTRA L DIABETES INSIP
(18 PALLETS CONTAINING 419 CARTONS) PHARMACEUTICALS AS UNDER DESMOPRESSIN ACET ATE TABLETS0.2MG 100S NDC CODE:68462027601 FDA PROD UCT CODE NO.: 61QCA03 H. T . S NO.: 2937.19.0000 ANDA NO.:201831 THERAPEUTICE U SE: - MANAGEM ENT OF CENTRA L DIABETES INSIP
53313, JAWAHARLAL NEHRU
"4601, NEW YORK/NEWARK AREA, NEWARK, NJ"
3,003
KG
18
PKG
***
USD
2022-02-21
1X40RH SAID TO CONTAIN 2621 CARTONS PACKED I UNDER GABAPENTIN TABLETS 600MG 500S NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69
1X40RH SAID TO CONTAIN 2621 CARTONS PACKED I UNDER GABAPENTIN TABLETS 600MG 500S NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69
53313, JAWAHARLAL NEHRU
1401, NORFOLK, VA
11,334
KG
2,621
CTN
***
USD
2021-04-14
PHARMACEUTICALS AS UNDER FLUOCINOLONE ACE BODODUCT CODE NO. 64 L C L 27 H. T. S NO. 3004 .49.00.50 ANDA NO. 210556 SYNTHETI
PHARMACEUTICALS AS UNDER FLUOCINOLONE ACE BODODUCT CODE NO. 64 L C L 27 H. T. S NO. 3004 .49.00.50 ANDA NO. 210556 SYNTHETI
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2,127
KG
12
PKG
***
USD
2021-02-23
25 PALLET CONTAINING 1952 CARTONS PHARMACEUT ICALS AS UNDER ATOMOXETINE CAPSU LES 100MG 30 S NDC CODE:68 462027130 FDA PRODUCT CODE NO. :64 UCA 99 H. T. S NO. :3004.90.92.90 ANDA NO.: 0 79019 TREATMENT OF ATTENTI ON -DEFICIT/HYPERACIVITY D ISORDER (ADHD ATOMOXETINE CAPSULES 60MG 30 S NDC COD E:68462026930 FDA PRODU CT CODE NO.:79019 H. T. S NO. :3004.90.92.90 ANDA NO.: 0 79019 THERAPEUTICE USE: -T REATMENT OF ATTENTION -DEF ICIT/HYPERACIVITY DISORDER (ADHD ATOMOXETINE CAPSULE S 80MG 30 S NDC CODE:68462 027030 FDA PRODUCT CODE NO .:64 UCA 99 H. T. S NO.:30 04.90.92.90 ANDA NO.: 0790 19 THERAPEUTICE USE: -ATOM OXETINE IS USED TO TREAT A TTENTION-DEFICIT HYPERACTI VITY DI SORDER NAPROXEN TAB LETS 500MG 100 S NDC CODE: 68462019001 FDA PRODUCT CO DE NO.:-62 G C A49 H. T. S NO.:3004.90.92.40 ANDA N O.:-78-2 50 THERAPEUTICE US E:-ANTI-INFLAMMATORY,ANALGESIC OMEPRAZOLE DR CAPSULE S 10MG 30 S NDC C ODE:68462 039530 FDA PRODUCT CODE NO .:62KCF10 H. T. S NO.:3004 .90.9160 ANDA NO.: 91672 THERAPEUTICE USE: --TREATME NT OF TREAT GASTR OESOPHAGE AL REFLUX DISEASE TOPIRAMA TE TABLETS 25MG 60 S NDC C ODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.49. 00.20 AN DA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT TOP IRAMATE TABLETS 50MG 1000 S NDC CODE:68462015310 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.49.0 0.20 ANDA NO.:- 77-627 THE RAPEUTICE USE:-ANTICONVULS AN T 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : + 20 DEGREES COMMERCIAL & CU STOM INVOICE NO. F20052004 180 DT. 21.01.2021 NET WT. 3,401.69 FREIGHT PREPAID NAMED ACCOUNT: GLENMARK P HARMACEUTICALS LIMITED T HE TEMPERATURE TO BE SET A T +20 DEGREE CELCIUS IN AC CORDA NCE WITH SHIPPER INST RUCTIONS
25 PALLET CONTAINING 1952 CARTONS PHARMACEUT ICALS AS UNDER ATOMOXETINE CAPSU LES 100MG 30 S NDC CODE:68 462027130 FDA PRODUCT CODE NO. :64 UCA 99 H. T. S NO. :3004.90.92.90 ANDA NO.: 0 79019 TREATMENT OF ATTENTI ON -DEFICIT/HYPERACIVITY D ISORDER (ADHD ATOMOXETINE CAPSULES 60MG 30 S NDC COD E:68462026930 FDA PRODU CT CODE NO.:79019 H. T. S NO. :3004.90.92.90 ANDA NO.: 0 79019 THERAPEUTICE USE: -T REATMENT OF ATTENTION -DEF ICIT/HYPERACIVITY DISORDER (ADHD ATOMOXETINE CAPSULE S 80MG 30 S NDC CODE:68462 027030 FDA PRODUCT CODE NO .:64 UCA 99 H. T. S NO.:30 04.90.92.90 ANDA NO.: 0790 19 THERAPEUTICE USE: -ATOM OXETINE IS USED TO TREAT A TTENTION-DEFICIT HYPERACTI VITY DI SORDER NAPROXEN TAB LETS 500MG 100 S NDC CODE: 68462019001 FDA PRODUCT CO DE NO.:-62 G C A49 H. T. S NO.:3004.90.92.40 ANDA N O.:-78-2 50 THERAPEUTICE US E:-ANTI-INFLAMMATORY,ANALGESIC OMEPRAZOLE DR CAPSULE S 10MG 30 S NDC C ODE:68462 039530 FDA PRODUCT CODE NO .:62KCF10 H. T. S NO.:3004 .90.9160 ANDA NO.: 91672 THERAPEUTICE USE: --TREATME NT OF TREAT GASTR OESOPHAGE AL REFLUX DISEASE TOPIRAMA TE TABLETS 25MG 60 S NDC C ODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.49. 00.20 AN DA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT TOP IRAMATE TABLETS 50MG 1000 S NDC CODE:68462015310 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.49.0 0.20 ANDA NO.:- 77-627 THE RAPEUTICE USE:-ANTICONVULS AN T 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : + 20 DEGREES COMMERCIAL & CU STOM INVOICE NO. F20052004 180 DT. 21.01.2021 NET WT. 3,401.69 FREIGHT PREPAID NAMED ACCOUNT: GLENMARK P HARMACEUTICALS LIMITED T HE TEMPERATURE TO BE SET A T +20 DEGREE CELCIUS IN AC CORDA NCE WITH SHIPPER INST RUCTIONS
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4,431
KG
25
PKG
***
USD